Traws Pharma, Inc. Income Statement
TRAW|12 years of annual SEC 10-K data (FY2013-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$226,000
FY2024
Gross Profit
N/A
FY2024
Operating Income
-$142M
FY2024
Net Income
-$167M
FY2024
Traws Pharma, Inc. reported $226,000 in revenue and $167M in net loss for FY2024. Revenue has declined at a 15.7% compound annual rate over the past 11 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $226.0K | $226.0K | $226.0K | $231.0K | $2.2M | $1.2M | $787.0K | $5.5M | $11.5M | $800.0K | $46.2M | $1.5M |
| SG&A Expense | $12.3M | $8.4M | $9.4M | $8.3M | $8.3M | $7.6M | $7.4M | $9.2M | $9.5M | $15.1M | $15.7M | $6.4M |
| R&D Expense | $12.8M | $11.4M | $7.3M | $16.9M | $15.5M | $16.9M | $19.1M | $20.1M | $25.9M | $49.4M | $52.8M | $22.6M |
| Operating Income | -$142.4M | -$19.6M | -$16.5M | -$25.0M | -$21.7M | -$23.3M | -$25.7M | -$23.7M | -$24.0M | -$63.7M | -$22.3M | -$27.6M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | $8.6M | $19.0K |
| Income Tax | - | - | - | $4.0K | $10.0K | -$124.0K | $13.0K | $14.0K | $16.0K | $19.0K | $435.0K | $432.0K |
| Net Income | -$166.5M | -$19.0M | -$16.2M | -$25.2M | -$21.5M | -$20.6M | -$24.1M | -$19.7M | -$24.0M | -$63.7M | -$29.9M | -$26.3M |
| EPS (Basic) | -$35.21 | -$0.91 | -$0.96 | -$2.17 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$35.21 | -$0.91 | -$0.96 | -$2.17 | -$1.49 | -$4.99 | -$40.15 | -$4.44 | -$10.54 | -$2.94 | -$15.35 | -$14.18 |
| Shares Outstanding | 3.7M | 20.9M | 20.9M | 11.6M | 111.2M | 5.7M | 718.1K | 6.8M | 2.5M | 21.7M | 21.5M | 2.6M |
| Operating Margin | -62997.3% | -8684.5% | -7299.1% | -10819.5% | -994.0% | -1895.9% | -3270.3% | -427.4% | -209.2% | -7968.0% | -48.2% | -1854.3% |
| Profit Margin | -73682.7% | -8391.1% | -7151.8% | -10890.5% | -985.0% | -1675.3% | -3061.3% | -354.6% | -209.3% | -7960.3% | -64.8% | -1768.3% |